nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—osteoarthritis—Methylprednisolone—multiple sclerosis	0.1	1	CpDpCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0646	0.21	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0622	0.202	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0622	0.202	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.06	0.196	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0581	0.189	CiPCiCtD
Prednisone—Methylprednisolone—multiple sclerosis	0.0468	0.207	CrCtD
Prednisone—Betamethasone—multiple sclerosis	0.0461	0.204	CrCtD
Prednisone—Dexamethasone—multiple sclerosis	0.0461	0.204	CrCtD
Prednisone—Triamcinolone—multiple sclerosis	0.045	0.199	CrCtD
Prednisone—Prednisolone—multiple sclerosis	0.0417	0.185	CrCtD
Prednisone—ALB—multiple sclerosis	0.0417	1	CbGaD
Prednisone—NR3C1—Methylprednisolone—multiple sclerosis	0.0156	0.155	CbGbCtD
Prednisone—NR3C1—Triamcinolone—multiple sclerosis	0.0118	0.117	CbGbCtD
Prednisone—NR3C1—Betamethasone—multiple sclerosis	0.0102	0.1	CbGbCtD
Prednisone—NR3C1—Prednisolone—multiple sclerosis	0.01	0.0991	CbGbCtD
Prednisone—SLCO1A2—Prednisolone—multiple sclerosis	0.00864	0.0854	CbGbCtD
Prednisone—NR3C1—Dexamethasone—multiple sclerosis	0.00591	0.0584	CbGbCtD
Prednisone—SLCO1A2—Dexamethasone—multiple sclerosis	0.00509	0.0504	CbGbCtD
Prednisone—SLCO1A2—Methotrexate—multiple sclerosis	0.00409	0.0405	CbGbCtD
Prednisone—ABCB1—Methylprednisolone—multiple sclerosis	0.00364	0.036	CbGbCtD
Prednisone—CYP3A4—Fingolimod—multiple sclerosis	0.00338	0.0335	CbGbCtD
Prednisone—Exemestane—Methylprednisolone—multiple sclerosis	0.00284	0.0178	CrCrCtD
Prednisone—ABCB1—Mitoxantrone—multiple sclerosis	0.00265	0.0263	CbGbCtD
Prednisone—Exemestane—Prednisolone—multiple sclerosis	0.00253	0.0158	CrCrCtD
Prednisone—ABCB1—Betamethasone—multiple sclerosis	0.00237	0.0234	CbGbCtD
Prednisone—ABCB1—Prednisolone—multiple sclerosis	0.00233	0.0231	CbGbCtD
Prednisone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00218	0.0216	CbGbCtD
Prednisone—ALB—Methotrexate—multiple sclerosis	0.00211	0.0209	CbGbCtD
Prednisone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00191	0.012	CrCrCtD
Prednisone—Ciclesonide—Methylprednisolone—multiple sclerosis	0.00189	0.0118	CrCrCtD
Prednisone—CYP2C19—Dexamethasone—multiple sclerosis	0.00171	0.0169	CbGbCtD
Prednisone—Ciclesonide—Prednisolone—multiple sclerosis	0.00168	0.0105	CrCrCtD
Prednisone—CYP3A4—Triamcinolone—multiple sclerosis	0.00165	0.0163	CbGbCtD
Prednisone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00159	0.0157	CbGbCtD
Prednisone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00158	0.00988	CrCrCtD
Prednisone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00153	0.00957	CrCrCtD
Prednisone—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00148	0.00929	CrCrCtD
Prednisone—Testolactone—Methylprednisolone—multiple sclerosis	0.00148	0.00929	CrCrCtD
Prednisone—Prednicarbate—Dexamethasone—multiple sclerosis	0.00146	0.00914	CrCrCtD
Prednisone—Testolactone—Dexamethasone—multiple sclerosis	0.00146	0.00914	CrCrCtD
Prednisone—Prednicarbate—Betamethasone—multiple sclerosis	0.00146	0.00914	CrCrCtD
Prednisone—Testolactone—Betamethasone—multiple sclerosis	0.00146	0.00914	CrCrCtD
Prednisone—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00144	0.00902	CrCrCtD
Prednisone—Prednicarbate—Triamcinolone—multiple sclerosis	0.00143	0.00893	CrCrCtD
Prednisone—Testolactone—Triamcinolone—multiple sclerosis	0.00143	0.00893	CrCrCtD
Prednisone—Fluocortolone—Betamethasone—multiple sclerosis	0.00142	0.00888	CrCrCtD
Prednisone—Fluocortolone—Dexamethasone—multiple sclerosis	0.00142	0.00888	CrCrCtD
Prednisone—CYP3A4—Betamethasone—multiple sclerosis	0.00142	0.014	CbGbCtD
Prednisone—Hydrocortamate—Prednisolone—multiple sclerosis	0.00141	0.0088	CrCrCtD
Prednisone—Alclometasone—Methylprednisolone—multiple sclerosis	0.0014	0.00877	CrCrCtD
Prednisone—CYP3A4—Prednisolone—multiple sclerosis	0.0014	0.0138	CbGbCtD
Prednisone—Fluocortolone—Triamcinolone—multiple sclerosis	0.00139	0.00868	CrCrCtD
Prednisone—Alclometasone—Betamethasone—multiple sclerosis	0.00138	0.00864	CrCrCtD
Prednisone—Alclometasone—Dexamethasone—multiple sclerosis	0.00138	0.00864	CrCrCtD
Prednisone—ABCB1—Dexamethasone—multiple sclerosis	0.00138	0.0136	CbGbCtD
Prednisone—Budesonide—Methylprednisolone—multiple sclerosis	0.00136	0.00854	CrCrCtD
Prednisone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00136	0.00853	CrCrCtD
Prednisone—Alclometasone—Triamcinolone—multiple sclerosis	0.00135	0.00844	CrCrCtD
Prednisone—Budesonide—Betamethasone—multiple sclerosis	0.00134	0.0084	CrCrCtD
Prednisone—Amcinonide—Dexamethasone—multiple sclerosis	0.00134	0.0084	CrCrCtD
Prednisone—Amcinonide—Betamethasone—multiple sclerosis	0.00134	0.0084	CrCrCtD
Prednisone—Budesonide—Dexamethasone—multiple sclerosis	0.00134	0.0084	CrCrCtD
Prednisone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00133	0.00832	CrCrCtD
Prednisone—Desonide—Methylprednisolone—multiple sclerosis	0.00133	0.00832	CrCrCtD
Prednisone—Diflorasone—Methylprednisolone—multiple sclerosis	0.00133	0.00832	CrCrCtD
Prednisone—Flunisolide—Methylprednisolone—multiple sclerosis	0.00133	0.00832	CrCrCtD
Prednisone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00133	0.00832	CrCrCtD
Prednisone—Testolactone—Prednisolone—multiple sclerosis	0.00132	0.00828	CrCrCtD
Prednisone—Prednicarbate—Prednisolone—multiple sclerosis	0.00132	0.00828	CrCrCtD
Prednisone—Amcinonide—Triamcinolone—multiple sclerosis	0.00131	0.00821	CrCrCtD
Prednisone—Budesonide—Triamcinolone—multiple sclerosis	0.00131	0.00821	CrCrCtD
Prednisone—Diflorasone—Dexamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Diflorasone—Betamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Desonide—Betamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Desonide—Dexamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Flunisolide—Betamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Flunisolide—Dexamethasone—multiple sclerosis	0.00131	0.00819	CrCrCtD
Prednisone—Paramethasone—Methylprednisolone—multiple sclerosis	0.0013	0.00811	CrCrCtD
Prednisone—Fluocortolone—Prednisolone—multiple sclerosis	0.00128	0.00804	CrCrCtD
Prednisone—Desonide—Triamcinolone—multiple sclerosis	0.00128	0.008	CrCrCtD
Prednisone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00128	0.008	CrCrCtD
Prednisone—Flunisolide—Triamcinolone—multiple sclerosis	0.00128	0.008	CrCrCtD
Prednisone—Diflorasone—Triamcinolone—multiple sclerosis	0.00128	0.008	CrCrCtD
Prednisone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00128	0.008	CrCrCtD
Prednisone—Paramethasone—Dexamethasone—multiple sclerosis	0.00127	0.00798	CrCrCtD
Prednisone—Paramethasone—Betamethasone—multiple sclerosis	0.00127	0.00798	CrCrCtD
Prednisone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00126	0.00791	CrCrCtD
Prednisone—Alclometasone—Prednisolone—multiple sclerosis	0.00125	0.00782	CrCrCtD
Prednisone—Paramethasone—Triamcinolone—multiple sclerosis	0.00125	0.0078	CrCrCtD
Prednisone—Desoximetasone—Betamethasone—multiple sclerosis	0.00124	0.00779	CrCrCtD
Prednisone—Desoximetasone—Dexamethasone—multiple sclerosis	0.00124	0.00779	CrCrCtD
Prednisone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00123	0.00773	CrCrCtD
Prednisone—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00123	0.00773	CrCrCtD
Prednisone—Mometasone—Methylprednisolone—multiple sclerosis	0.00123	0.00773	CrCrCtD
Prednisone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00123	0.00773	CrCrCtD
Prednisone—Loteprednol—Methylprednisolone—multiple sclerosis	0.00123	0.00773	CrCrCtD
Prednisone—Desoximetasone—Triamcinolone—multiple sclerosis	0.00122	0.00761	CrCrCtD
Prednisone—Amcinonide—Prednisolone—multiple sclerosis	0.00122	0.00761	CrCrCtD
Prednisone—Budesonide—Prednisolone—multiple sclerosis	0.00122	0.00761	CrCrCtD
Prednisone—Triamcinolone—Dexamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Mometasone—Betamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Triamcinolone—Betamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Loteprednol—Dexamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Loteprednol—Betamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Fluorometholone—Dexamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Fluorometholone—Betamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Mometasone—Dexamethasone—multiple sclerosis	0.00121	0.0076	CrCrCtD
Prednisone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00121	0.00755	CrCrCtD
Prednisone—Rimexolone—Methylprednisolone—multiple sclerosis	0.00121	0.00755	CrCrCtD
Prednisone—Betamethasone—Methylprednisolone—multiple sclerosis	0.00121	0.00755	CrCrCtD
Prednisone—Betamethasone—Dexamethasone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Dexamethasone—Betamethasone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Rimexolone—Dexamethasone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Rimexolone—Betamethasone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Loteprednol—Triamcinolone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Mometasone—Triamcinolone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Fluorometholone—Triamcinolone—multiple sclerosis	0.00119	0.00743	CrCrCtD
Prednisone—Diflorasone—Prednisolone—multiple sclerosis	0.00118	0.00741	CrCrCtD
Prednisone—Fludrocortisone—Prednisolone—multiple sclerosis	0.00118	0.00741	CrCrCtD
Prednisone—Desonide—Prednisolone—multiple sclerosis	0.00118	0.00741	CrCrCtD
Prednisone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00118	0.00741	CrCrCtD
Prednisone—Flunisolide—Prednisolone—multiple sclerosis	0.00118	0.00741	CrCrCtD
Prednisone—Betamethasone—Triamcinolone—multiple sclerosis	0.00116	0.00726	CrCrCtD
Prednisone—Dexamethasone—Triamcinolone—multiple sclerosis	0.00116	0.00726	CrCrCtD
Prednisone—Rimexolone—Triamcinolone—multiple sclerosis	0.00116	0.00726	CrCrCtD
Prednisone—Paramethasone—Prednisolone—multiple sclerosis	0.00115	0.00722	CrCrCtD
Prednisone—Methyltestosterone—Prednisolone—multiple sclerosis	0.00115	0.00722	CrCrCtD
Prednisone—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00114	0.00711	CrCrCtD
Prednisone—Methylprednisolone—Betamethasone—multiple sclerosis	0.00114	0.00711	CrCrCtD
Prednisone—Prednisolone—Methylprednisolone—multiple sclerosis	0.00113	0.00707	CrCrCtD
Prednisone—Desoximetasone—Prednisolone—multiple sclerosis	0.00113	0.00705	CrCrCtD
Prednisone—Prednisolone—Dexamethasone—multiple sclerosis	0.00111	0.00696	CrCrCtD
Prednisone—Prednisolone—Betamethasone—multiple sclerosis	0.00111	0.00696	CrCrCtD
Prednisone—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00111	0.00694	CrCrCtD
Prednisone—ABCB1—Methotrexate—multiple sclerosis	0.00111	0.0109	CbGbCtD
Prednisone—Triamcinolone—Prednisolone—multiple sclerosis	0.0011	0.00688	CrCrCtD
Prednisone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.0011	0.00688	CrCrCtD
Prednisone—Mometasone—Prednisolone—multiple sclerosis	0.0011	0.00688	CrCrCtD
Prednisone—Fluorometholone—Prednisolone—multiple sclerosis	0.0011	0.00688	CrCrCtD
Prednisone—Loteprednol—Prednisolone—multiple sclerosis	0.0011	0.00688	CrCrCtD
Prednisone—Prednisolone—Triamcinolone—multiple sclerosis	0.00109	0.0068	CrCrCtD
Prednisone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00108	0.00678	CrCrCtD
Prednisone—Betamethasone—Prednisolone—multiple sclerosis	0.00107	0.00672	CrCrCtD
Prednisone—Dexamethasone—Prednisolone—multiple sclerosis	0.00107	0.00672	CrCrCtD
Prednisone—Rimexolone—Prednisolone—multiple sclerosis	0.00107	0.00672	CrCrCtD
Prednisone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00107	0.00668	CrCrCtD
Prednisone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00107	0.00668	CrCrCtD
Prednisone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00104	0.00652	CrCrCtD
Prednisone—Methylprednisolone—Prednisolone—multiple sclerosis	0.00103	0.00643	CrCrCtD
Prednisone—Hydrocortisone—Prednisolone—multiple sclerosis	0.000965	0.00604	CrCrCtD
Prednisone—CYP3A4—Dexamethasone—multiple sclerosis	0.000824	0.00816	CbGbCtD
Prednisone—HSD11B1—medulla oblongata—multiple sclerosis	0.000288	0.0972	CbGeAlD
Prednisone—HSD11B1—midbrain—multiple sclerosis	0.000263	0.0888	CbGeAlD
Prednisone—HSD11B1—spinal cord—multiple sclerosis	0.000257	0.0867	CbGeAlD
Prednisone—HSD11B1—nervous system—multiple sclerosis	0.000216	0.073	CbGeAlD
Prednisone—HSD11B1—central nervous system—multiple sclerosis	0.000208	0.0703	CbGeAlD
Prednisone—HSD11B1—cerebellum—multiple sclerosis	0.000204	0.0687	CbGeAlD
Prednisone—NR3C1—nerve—multiple sclerosis	0.000182	0.0615	CbGeAlD
Prednisone—HSD11B1—brain—multiple sclerosis	0.000165	0.0558	CbGeAlD
Prednisone—Danazol—CCL2—multiple sclerosis	0.000129	0.339	CrCbGaD
Prednisone—SLCO1A2—medulla oblongata—multiple sclerosis	8.71e-05	0.0294	CbGeAlD
Prednisone—SLCO1A2—midbrain—multiple sclerosis	7.96e-05	0.0269	CbGeAlD
Prednisone—Danazol—PGR—multiple sclerosis	7.89e-05	0.206	CrCbGaD
Prednisone—NR3C1—brainstem—multiple sclerosis	7.82e-05	0.0264	CbGeAlD
Prednisone—SLCO1A2—spinal cord—multiple sclerosis	7.77e-05	0.0262	CbGeAlD
Prednisone—SLCO1A2—nervous system—multiple sclerosis	6.55e-05	0.0221	CbGeAlD
Prednisone—Betamethasone—PGR—multiple sclerosis	6.43e-05	0.168	CrCbGaD
Prednisone—SLCO1A2—central nervous system—multiple sclerosis	6.3e-05	0.0213	CbGeAlD
Prednisone—SLCO1A2—cerebellum—multiple sclerosis	6.16e-05	0.0208	CbGeAlD
Prednisone—NR3C1—medulla oblongata—multiple sclerosis	5.45e-05	0.0184	CbGeAlD
Prednisone—Triamcinolone—BCHE—multiple sclerosis	5.37e-05	0.14	CrCbGaD
Prednisone—SLCO1A2—brain—multiple sclerosis	5e-05	0.0169	CbGeAlD
Prednisone—NR3C1—midbrain—multiple sclerosis	4.98e-05	0.0168	CbGeAlD
Prednisone—ALB—brain—multiple sclerosis	4.97e-05	0.0168	CbGeAlD
Prednisone—NR3C1—spinal cord—multiple sclerosis	4.86e-05	0.0164	CbGeAlD
Prednisone—NR3C1—nervous system—multiple sclerosis	4.1e-05	0.0138	CbGeAlD
Prednisone—ABCB1—retina—multiple sclerosis	4.04e-05	0.0136	CbGeAlD
Prednisone—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	3.98e-05	0.00433	CbGpPWpGaD
Prednisone—NR3C1—central nervous system—multiple sclerosis	3.94e-05	0.0133	CbGeAlD
Prednisone—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	3.89e-05	0.00424	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—RRM1—multiple sclerosis	3.86e-05	0.00421	CbGpPWpGaD
Prednisone—NR3C1—cerebellum—multiple sclerosis	3.85e-05	0.013	CbGeAlD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	3.8e-05	0.00414	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	3.74e-05	0.00408	CbGpPWpGaD
Prednisone—Dexamethasone—PGR—multiple sclerosis	3.74e-05	0.0978	CrCbGaD
Prednisone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	3.72e-05	0.00406	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—C4A—multiple sclerosis	3.68e-05	0.00401	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	3.32e-05	0.00362	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	3.32e-05	0.00362	CbGpPWpGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.28e-05	0.00357	CbGpPWpGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.28e-05	0.00357	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	3.26e-05	0.00355	CbGpPWpGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	3.21e-05	0.00349	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.18e-05	0.00346	CbGpPWpGaD
Prednisone—NR3C1—brain—multiple sclerosis	3.13e-05	0.0106	CbGeAlD
Prednisone—CYP3A4—nervous system—multiple sclerosis	3.1e-05	0.0105	CbGeAlD
Prednisone—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	3.07e-05	0.00334	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	3.01e-05	0.00328	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	3e-05	0.00327	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	3e-05	0.00327	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3e-05	0.00326	CbGpPWpGaD
Prednisone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.98e-05	0.00325	CbGpPWpGaD
Prednisone—CYP3A4—central nervous system—multiple sclerosis	2.98e-05	0.0101	CbGeAlD
Prednisone—ABCB1—medulla oblongata—multiple sclerosis	2.92e-05	0.00985	CbGeAlD
Prednisone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	2.83e-05	0.00308	CbGpPWpGaD
Prednisone—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	2.81e-05	0.00306	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.78e-05	0.00303	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	2.75e-05	0.00299	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	2.73e-05	0.00297	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	2.71e-05	0.00296	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	2.69e-05	0.00294	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	2.69e-05	0.00294	CbGpPWpGaD
Prednisone—ABCB1—midbrain—multiple sclerosis	2.67e-05	0.009	CbGeAlD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	2.64e-05	0.00288	CbGpPWpGaD
Prednisone—ABCB1—spinal cord—multiple sclerosis	2.6e-05	0.00878	CbGeAlD
Prednisone—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	2.59e-05	0.00282	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	2.58e-05	0.00282	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	2.57e-05	0.0028	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.57e-05	0.0028	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	2.51e-05	0.00274	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	2.49e-05	0.00271	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	2.42e-05	0.00264	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	2.38e-05	0.00259	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	2.38e-05	0.00259	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.35e-05	0.00256	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.35e-05	0.00256	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.35e-05	0.00256	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	2.34e-05	0.00255	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	2.24e-05	0.00244	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.22e-05	0.00242	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—BCHE—multiple sclerosis	2.22e-05	0.00242	CbGpPWpGaD
Prednisone—ABCB1—nervous system—multiple sclerosis	2.19e-05	0.0074	CbGeAlD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	2.19e-05	0.00239	CbGpPWpGaD
Prednisone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	2.19e-05	0.00238	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.13e-05	0.00232	CbGpPWpGaD
Prednisone—ABCB1—central nervous system—multiple sclerosis	2.11e-05	0.00712	CbGeAlD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.08e-05	0.00227	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.08e-05	0.00227	CbGpPWpGaD
Prednisone—ABCB1—cerebellum—multiple sclerosis	2.06e-05	0.00696	CbGeAlD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	2.05e-05	0.00223	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	2.03e-05	0.00221	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	1.97e-05	0.00215	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	1.95e-05	0.00213	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	1.92e-05	0.0021	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	1.88e-05	0.00205	CbGpPWpGaD
Prednisone—Methyltestosterone—ALB—multiple sclerosis	1.87e-05	0.049	CrCbGaD
Prednisone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	1.87e-05	0.00204	CbGpPWpGaD
Prednisone—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	1.87e-05	0.00203	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	1.84e-05	0.002	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	1.8e-05	0.00196	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	1.77e-05	0.00193	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	1.77e-05	0.00193	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL4—multiple sclerosis	1.77e-05	0.00192	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	1.76e-05	0.00192	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	1.72e-05	0.00188	CbGpPWpGaD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.71e-05	0.00187	CbGpPWpGaD
Prednisone—ABCB1—brain—multiple sclerosis	1.68e-05	0.00566	CbGeAlD
Prednisone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	1.66e-05	0.00181	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.62e-05	0.00176	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.62e-05	0.00176	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	1.56e-05	0.0017	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.56e-05	0.0017	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.55e-05	0.00169	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.54e-05	0.00168	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	1.54e-05	0.00168	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.49e-05	0.00162	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CD58—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SELPLG—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MERTK—multiple sclerosis	1.48e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.46e-05	0.00159	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.46e-05	0.00159	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.43e-05	0.00156	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.43e-05	0.00156	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.41e-05	0.00154	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.41e-05	0.00154	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.41e-05	0.00153	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—ICAM1—multiple sclerosis	1.4e-05	0.00153	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.4e-05	0.00152	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.38e-05	0.0015	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.38e-05	0.0015	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.35e-05	0.00147	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.34e-05	0.00146	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—APOE—multiple sclerosis	1.33e-05	0.00145	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SRM—multiple sclerosis	1.32e-05	0.00144	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	1.31e-05	0.00143	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.31e-05	0.00143	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.28e-05	0.00139	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—CCL2—multiple sclerosis	1.26e-05	0.00137	CbGpPWpGaD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.24e-05	0.00135	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.24e-05	0.00135	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.23e-05	0.00134	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.21e-05	0.00132	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.18e-05	0.00128	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	1.17e-05	0.00128	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.15e-05	0.00126	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.15e-05	0.00125	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—POMC—multiple sclerosis	1.15e-05	0.00125	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.13e-05	0.00123	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.11e-05	0.00121	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.11e-05	0.00121	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.09e-05	0.00118	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.07e-05	0.00116	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—ALB—multiple sclerosis	1.05e-05	0.00114	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.04e-05	0.00113	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.03e-05	0.00112	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.03e-05	0.00112	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.02e-05	0.00111	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.02e-05	0.00111	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.02e-05	0.00111	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.02e-05	0.00111	CbGpPWpGaD
Prednisone—Dyspepsia—Mitoxantrone—multiple sclerosis	1.02e-05	0.000196	CcSEcCtD
Prednisone—Angiopathy—Dexamethasone—multiple sclerosis	1.01e-05	0.000195	CcSEcCtD
Prednisone—Angiopathy—Betamethasone—multiple sclerosis	1.01e-05	0.000195	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.01e-05	0.0011	CbGpPWpGaD
Prednisone—Convulsion—Prednisolone—multiple sclerosis	1.01e-05	0.000194	CcSEcCtD
Prednisone—Decreased appetite—Mitoxantrone—multiple sclerosis	1e-05	0.000194	CcSEcCtD
Prednisone—Hypertension—Prednisolone—multiple sclerosis	1e-05	0.000193	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	9.98e-06	0.00109	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	9.95e-06	0.00108	CbGpPWpGaD
Prednisone—Fatigue—Mitoxantrone—multiple sclerosis	9.95e-06	0.000192	CcSEcCtD
Prednisone—Arrhythmia—Dexamethasone—multiple sclerosis	9.93e-06	0.000192	CcSEcCtD
Prednisone—Arrhythmia—Betamethasone—multiple sclerosis	9.93e-06	0.000192	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—multiple sclerosis	9.91e-06	0.000191	CcSEcCtD
Prednisone—Ill-defined disorder—Triamcinolone—multiple sclerosis	9.9e-06	0.000191	CcSEcCtD
Prednisone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.88e-06	0.000191	CcSEcCtD
Prednisone—Constipation—Mitoxantrone—multiple sclerosis	9.87e-06	0.00019	CcSEcCtD
Prednisone—Alopecia—Betamethasone—multiple sclerosis	9.83e-06	0.00019	CcSEcCtD
Prednisone—Alopecia—Dexamethasone—multiple sclerosis	9.83e-06	0.00019	CcSEcCtD
Prednisone—Diarrhoea—Azathioprine—multiple sclerosis	9.77e-06	0.000188	CcSEcCtD
Prednisone—Discomfort—Prednisolone—multiple sclerosis	9.76e-06	0.000188	CcSEcCtD
Prednisone—Angioedema—Triamcinolone—multiple sclerosis	9.75e-06	0.000188	CcSEcCtD
Prednisone—Angioedema—Methylprednisolone—multiple sclerosis	9.73e-06	0.000188	CcSEcCtD
Prednisone—Erythema—Betamethasone—multiple sclerosis	9.68e-06	0.000187	CcSEcCtD
Prednisone—Erythema—Dexamethasone—multiple sclerosis	9.68e-06	0.000187	CcSEcCtD
Prednisone—Malaise—Triamcinolone—multiple sclerosis	9.62e-06	0.000186	CcSEcCtD
Prednisone—Malaise—Methylprednisolone—multiple sclerosis	9.6e-06	0.000185	CcSEcCtD
Prednisone—Vertigo—Triamcinolone—multiple sclerosis	9.58e-06	0.000185	CcSEcCtD
Prednisone—Syncope—Triamcinolone—multiple sclerosis	9.57e-06	0.000185	CcSEcCtD
Prednisone—Vertigo—Methylprednisolone—multiple sclerosis	9.56e-06	0.000185	CcSEcCtD
Prednisone—Syncope—Methylprednisolone—multiple sclerosis	9.54e-06	0.000184	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IL1B—multiple sclerosis	9.52e-06	0.00104	CbGpPWpGaD
Prednisone—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.51e-06	0.000184	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IL2—multiple sclerosis	9.49e-06	0.00103	CbGpPWpGaD
Prednisone—Anaphylactic shock—Prednisolone—multiple sclerosis	9.47e-06	0.000183	CcSEcCtD
Prednisone—Oedema—Prednisolone—multiple sclerosis	9.47e-06	0.000183	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—multiple sclerosis	9.45e-06	0.000182	CcSEcCtD
Prednisone—Dizziness—Azathioprine—multiple sclerosis	9.44e-06	0.000182	CcSEcCtD
Prednisone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9.44e-06	0.000182	CcSEcCtD
Prednisone—Loss of consciousness—Triamcinolone—multiple sclerosis	9.38e-06	0.000181	CcSEcCtD
Prednisone—Loss of consciousness—Methylprednisolone—multiple sclerosis	9.35e-06	0.000181	CcSEcCtD
Prednisone—Shock—Prednisolone—multiple sclerosis	9.31e-06	0.00018	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—multiple sclerosis	9.31e-06	0.00018	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	9.28e-06	0.00101	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	9.28e-06	0.00101	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	9.25e-06	0.00101	CbGpPWpGaD
Prednisone—Convulsion—Triamcinolone—multiple sclerosis	9.24e-06	0.000178	CcSEcCtD
Prednisone—Tachycardia—Prednisolone—multiple sclerosis	9.24e-06	0.000178	CcSEcCtD
Prednisone—Convulsion—Methylprednisolone—multiple sclerosis	9.22e-06	0.000178	CcSEcCtD
Prednisone—Hypertension—Triamcinolone—multiple sclerosis	9.21e-06	0.000178	CcSEcCtD
Prednisone—Hypertension—Methylprednisolone—multiple sclerosis	9.19e-06	0.000177	CcSEcCtD
Prednisone—Urticaria—Mitoxantrone—multiple sclerosis	9.17e-06	0.000177	CcSEcCtD
Prednisone—Hyperhidrosis—Prednisolone—multiple sclerosis	9.15e-06	0.000177	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.14e-06	0.000996	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.14e-06	0.000996	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.12e-06	0.000994	CbGpPWpGaD
Prednisone—Abdominal pain—Mitoxantrone—multiple sclerosis	9.12e-06	0.000176	CcSEcCtD
Prednisone—Body temperature increased—Mitoxantrone—multiple sclerosis	9.12e-06	0.000176	CcSEcCtD
Prednisone—ALB—Hemostasis—PLEK—multiple sclerosis	9.12e-06	0.000993	CbGpPWpGaD
Prednisone—Myalgia—Triamcinolone—multiple sclerosis	9.08e-06	0.000175	CcSEcCtD
Prednisone—Vomiting—Azathioprine—multiple sclerosis	9.08e-06	0.000175	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.07e-06	0.000988	CbGpPWpGaD
Prednisone—Myalgia—Methylprednisolone—multiple sclerosis	9.06e-06	0.000175	CcSEcCtD
Prednisone—Arthralgia—Methylprednisolone—multiple sclerosis	9.06e-06	0.000175	CcSEcCtD
Prednisone—Anxiety—Methylprednisolone—multiple sclerosis	9.03e-06	0.000174	CcSEcCtD
Prednisone—Rash—Azathioprine—multiple sclerosis	9e-06	0.000174	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	9e-06	0.000174	CcSEcCtD
Prednisone—Dermatitis—Azathioprine—multiple sclerosis	8.99e-06	0.000174	CcSEcCtD
Prednisone—Depression—Methotrexate—multiple sclerosis	8.99e-06	0.000173	CcSEcCtD
Prednisone—Ill-defined disorder—Betamethasone—multiple sclerosis	8.98e-06	0.000173	CcSEcCtD
Prednisone—Ill-defined disorder—Dexamethasone—multiple sclerosis	8.98e-06	0.000173	CcSEcCtD
Prednisone—Discomfort—Triamcinolone—multiple sclerosis	8.97e-06	0.000173	CcSEcCtD
Prednisone—Discomfort—Methylprednisolone—multiple sclerosis	8.95e-06	0.000173	CcSEcCtD
Prednisone—Headache—Azathioprine—multiple sclerosis	8.94e-06	0.000173	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.87e-06	0.000966	CbGpPWpGaD
Prednisone—Angioedema—Dexamethasone—multiple sclerosis	8.84e-06	0.000171	CcSEcCtD
Prednisone—Angioedema—Betamethasone—multiple sclerosis	8.84e-06	0.000171	CcSEcCtD
Prednisone—Malaise—Dexamethasone—multiple sclerosis	8.73e-06	0.000168	CcSEcCtD
Prednisone—Malaise—Betamethasone—multiple sclerosis	8.73e-06	0.000168	CcSEcCtD
Prednisone—Oedema—Triamcinolone—multiple sclerosis	8.71e-06	0.000168	CcSEcCtD
Prednisone—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.71e-06	0.000168	CcSEcCtD
Prednisone—Vertigo—Betamethasone—multiple sclerosis	8.7e-06	0.000168	CcSEcCtD
Prednisone—Vertigo—Dexamethasone—multiple sclerosis	8.7e-06	0.000168	CcSEcCtD
Prednisone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.69e-06	0.000168	CcSEcCtD
Prednisone—Syncope—Dexamethasone—multiple sclerosis	8.68e-06	0.000168	CcSEcCtD
Prednisone—Syncope—Betamethasone—multiple sclerosis	8.68e-06	0.000168	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	8.68e-06	0.000945	CbGpPWpGaD
Prednisone—Infection—Triamcinolone—multiple sclerosis	8.65e-06	0.000167	CcSEcCtD
Prednisone—Infection—Methylprednisolone—multiple sclerosis	8.63e-06	0.000167	CcSEcCtD
Prednisone—Shock—Triamcinolone—multiple sclerosis	8.57e-06	0.000165	CcSEcCtD
Prednisone—Insomnia—Prednisolone—multiple sclerosis	8.56e-06	0.000165	CcSEcCtD
Prednisone—Shock—Methylprednisolone—multiple sclerosis	8.55e-06	0.000165	CcSEcCtD
Prednisone—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.52e-06	0.000164	CcSEcCtD
Prednisone—Loss of consciousness—Betamethasone—multiple sclerosis	8.51e-06	0.000164	CcSEcCtD
Prednisone—Loss of consciousness—Dexamethasone—multiple sclerosis	8.51e-06	0.000164	CcSEcCtD
Prednisone—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.5e-06	0.000164	CcSEcCtD
Prednisone—Paraesthesia—Prednisolone—multiple sclerosis	8.5e-06	0.000164	CcSEcCtD
Prednisone—Tachycardia—Triamcinolone—multiple sclerosis	8.5e-06	0.000164	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	8.49e-06	0.000925	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GPC5—multiple sclerosis	8.49e-06	0.000925	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	8.48e-06	0.000924	CbGpPWpGaD
Prednisone—Nausea—Azathioprine—multiple sclerosis	8.48e-06	0.000164	CcSEcCtD
Prednisone—Tachycardia—Methylprednisolone—multiple sclerosis	8.48e-06	0.000164	CcSEcCtD
Prednisone—Skin disorder—Methylprednisolone—multiple sclerosis	8.44e-06	0.000163	CcSEcCtD
Prednisone—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.42e-06	0.000162	CcSEcCtD
Prednisone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.4e-06	0.000162	CcSEcCtD
Prednisone—Convulsion—Dexamethasone—multiple sclerosis	8.39e-06	0.000162	CcSEcCtD
Prednisone—Convulsion—Betamethasone—multiple sclerosis	8.39e-06	0.000162	CcSEcCtD
Prednisone—Hypertension—Betamethasone—multiple sclerosis	8.36e-06	0.000161	CcSEcCtD
Prednisone—Hypertension—Dexamethasone—multiple sclerosis	8.36e-06	0.000161	CcSEcCtD
Prednisone—Asthenia—Mitoxantrone—multiple sclerosis	8.28e-06	0.00016	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	8.25e-06	0.000899	CbGpPWpGaD
Prednisone—Myalgia—Betamethasone—multiple sclerosis	8.24e-06	0.000159	CcSEcCtD
Prednisone—Myalgia—Dexamethasone—multiple sclerosis	8.24e-06	0.000159	CcSEcCtD
Prednisone—Anxiety—Dexamethasone—multiple sclerosis	8.21e-06	0.000158	CcSEcCtD
Prednisone—Anxiety—Betamethasone—multiple sclerosis	8.21e-06	0.000158	CcSEcCtD
Prednisone—Discomfort—Dexamethasone—multiple sclerosis	8.14e-06	0.000157	CcSEcCtD
Prednisone—Discomfort—Betamethasone—multiple sclerosis	8.14e-06	0.000157	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—multiple sclerosis	8.13e-06	0.000157	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.1e-06	0.000883	CbGpPWpGaD
Prednisone—Haemorrhage—Methotrexate—multiple sclerosis	8.09e-06	0.000156	CcSEcCtD
Prednisone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	8.09e-06	0.000881	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8e-06	0.000871	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.93e-06	0.000153	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.91e-06	0.000153	CcSEcCtD
Prednisone—Oedema—Dexamethasone—multiple sclerosis	7.9e-06	0.000152	CcSEcCtD
Prednisone—Anaphylactic shock—Betamethasone—multiple sclerosis	7.9e-06	0.000152	CcSEcCtD
Prednisone—Oedema—Betamethasone—multiple sclerosis	7.9e-06	0.000152	CcSEcCtD
Prednisone—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.9e-06	0.000152	CcSEcCtD
Prednisone—Diarrhoea—Mitoxantrone—multiple sclerosis	7.9e-06	0.000152	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.89e-06	0.00086	CbGpPWpGaD
Prednisone—Insomnia—Triamcinolone—multiple sclerosis	7.87e-06	0.000152	CcSEcCtD
Prednisone—Insomnia—Methylprednisolone—multiple sclerosis	7.86e-06	0.000152	CcSEcCtD
Prednisone—Infection—Dexamethasone—multiple sclerosis	7.85e-06	0.000151	CcSEcCtD
Prednisone—Infection—Betamethasone—multiple sclerosis	7.85e-06	0.000151	CcSEcCtD
Prednisone—Paraesthesia—Triamcinolone—multiple sclerosis	7.82e-06	0.000151	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7.81e-06	0.00085	CbGpPWpGaD
Prednisone—Feeling abnormal—Prednisolone—multiple sclerosis	7.8e-06	0.000151	CcSEcCtD
Prednisone—Paraesthesia—Methylprednisolone—multiple sclerosis	7.8e-06	0.000151	CcSEcCtD
Prednisone—Shock—Betamethasone—multiple sclerosis	7.77e-06	0.00015	CcSEcCtD
Prednisone—Shock—Dexamethasone—multiple sclerosis	7.77e-06	0.00015	CcSEcCtD
Prednisone—Nervous system disorder—Betamethasone—multiple sclerosis	7.75e-06	0.00015	CcSEcCtD
Prednisone—Nervous system disorder—Dexamethasone—multiple sclerosis	7.75e-06	0.00015	CcSEcCtD
Prednisone—Tachycardia—Dexamethasone—multiple sclerosis	7.71e-06	0.000149	CcSEcCtD
Prednisone—Tachycardia—Betamethasone—multiple sclerosis	7.71e-06	0.000149	CcSEcCtD
Prednisone—Dyspepsia—Triamcinolone—multiple sclerosis	7.66e-06	0.000148	CcSEcCtD
Prednisone—Dyspepsia—Methylprednisolone—multiple sclerosis	7.65e-06	0.000148	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	7.65e-06	0.000833	CbGpPWpGaD
Prednisone—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.64e-06	0.000147	CcSEcCtD
Prednisone—Hyperhidrosis—Betamethasone—multiple sclerosis	7.64e-06	0.000147	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	7.57e-06	0.000825	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	7.57e-06	0.000824	CbGpPWpGaD
Prednisone—Eye disorder—Methotrexate—multiple sclerosis	7.56e-06	0.000146	CcSEcCtD
Prednisone—Anorexia—Dexamethasone—multiple sclerosis	7.53e-06	0.000145	CcSEcCtD
Prednisone—Anorexia—Betamethasone—multiple sclerosis	7.53e-06	0.000145	CcSEcCtD
Prednisone—Urticaria—Prednisolone—multiple sclerosis	7.52e-06	0.000145	CcSEcCtD
Prednisone—Fatigue—Triamcinolone—multiple sclerosis	7.51e-06	0.000145	CcSEcCtD
Prednisone—Fatigue—Methylprednisolone—multiple sclerosis	7.49e-06	0.000145	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.48e-06	0.000815	CbGpPWpGaD
Prednisone—Angiopathy—Methotrexate—multiple sclerosis	7.34e-06	0.000142	CcSEcCtD
Prednisone—Vomiting—Mitoxantrone—multiple sclerosis	7.34e-06	0.000142	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—multiple sclerosis	7.31e-06	0.000141	CcSEcCtD
Prednisone—Rash—Mitoxantrone—multiple sclerosis	7.28e-06	0.00014	CcSEcCtD
Prednisone—Dermatitis—Mitoxantrone—multiple sclerosis	7.27e-06	0.00014	CcSEcCtD
Prednisone—Headache—Mitoxantrone—multiple sclerosis	7.23e-06	0.00014	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.23e-06	0.000787	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.2e-06	0.000784	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.2e-06	0.000139	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.2e-06	0.000139	CcSEcCtD
Prednisone—Feeling abnormal—Triamcinolone—multiple sclerosis	7.17e-06	0.000138	CcSEcCtD
Prednisone—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.16e-06	0.000138	CcSEcCtD
Prednisone—Alopecia—Methotrexate—multiple sclerosis	7.15e-06	0.000138	CcSEcCtD
Prednisone—Insomnia—Betamethasone—multiple sclerosis	7.14e-06	0.000138	CcSEcCtD
Prednisone—Insomnia—Dexamethasone—multiple sclerosis	7.14e-06	0.000138	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.12e-06	0.000776	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.1e-06	0.000137	CcSEcCtD
Prednisone—Paraesthesia—Betamethasone—multiple sclerosis	7.09e-06	0.000137	CcSEcCtD
Prednisone—Paraesthesia—Dexamethasone—multiple sclerosis	7.09e-06	0.000137	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—multiple sclerosis	7.09e-06	0.000137	CcSEcCtD
Prednisone—Erythema—Methotrexate—multiple sclerosis	7.04e-06	0.000136	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—multiple sclerosis	7.04e-06	0.000136	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—RRM1—multiple sclerosis	7.03e-06	0.000766	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	7.02e-06	0.000765	CbGpPWpGaD
Prednisone—Hypersensitivity—Prednisolone—multiple sclerosis	6.97e-06	0.000135	CcSEcCtD
Prednisone—Dyspepsia—Dexamethasone—multiple sclerosis	6.95e-06	0.000134	CcSEcCtD
Prednisone—Dyspepsia—Betamethasone—multiple sclerosis	6.95e-06	0.000134	CcSEcCtD
Prednisone—Urticaria—Triamcinolone—multiple sclerosis	6.92e-06	0.000133	CcSEcCtD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.92e-06	0.000753	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—multiple sclerosis	6.91e-06	0.000753	CbGpPWpGaD
Prednisone—Urticaria—Methylprednisolone—multiple sclerosis	6.9e-06	0.000133	CcSEcCtD
Prednisone—Body temperature increased—Triamcinolone—multiple sclerosis	6.88e-06	0.000133	CcSEcCtD
Prednisone—Abdominal pain—Methylprednisolone—multiple sclerosis	6.87e-06	0.000133	CcSEcCtD
Prednisone—Decreased appetite—Betamethasone—multiple sclerosis	6.87e-06	0.000133	CcSEcCtD
Prednisone—Decreased appetite—Dexamethasone—multiple sclerosis	6.87e-06	0.000133	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	6.85e-06	0.000747	CbGpPWpGaD
Prednisone—Nausea—Mitoxantrone—multiple sclerosis	6.85e-06	0.000132	CcSEcCtD
Prednisone—Fatigue—Dexamethasone—multiple sclerosis	6.81e-06	0.000131	CcSEcCtD
Prednisone—Fatigue—Betamethasone—multiple sclerosis	6.81e-06	0.000131	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—multiple sclerosis	6.64e-06	0.000128	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—TNF—multiple sclerosis	6.55e-06	0.000714	CbGpPWpGaD
Prednisone—Ill-defined disorder—Methotrexate—multiple sclerosis	6.54e-06	0.000126	CcSEcCtD
Prednisone—Anaemia—Methotrexate—multiple sclerosis	6.51e-06	0.000126	CcSEcCtD
Prednisone—Feeling abnormal—Betamethasone—multiple sclerosis	6.51e-06	0.000126	CcSEcCtD
Prednisone—Feeling abnormal—Dexamethasone—multiple sclerosis	6.51e-06	0.000126	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	6.46e-06	0.000704	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.46e-06	0.000125	CcSEcCtD
Prednisone—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.46e-06	0.000125	CcSEcCtD
Prednisone—ALB—Metabolism—SRM—multiple sclerosis	6.44e-06	0.000701	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SELE—multiple sclerosis	6.42e-06	0.0007	CbGpPWpGaD
Prednisone—Hypersensitivity—Triamcinolone—multiple sclerosis	6.41e-06	0.000124	CcSEcCtD
Prednisone—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.4e-06	0.000124	CcSEcCtD
Prednisone—Malaise—Methotrexate—multiple sclerosis	6.35e-06	0.000123	CcSEcCtD
Prednisone—ALB—Platelet degranulation—TGFB1—multiple sclerosis	6.35e-06	0.000691	CbGpPWpGaD
Prednisone—Vertigo—Methotrexate—multiple sclerosis	6.33e-06	0.000122	CcSEcCtD
Prednisone—Urticaria—Betamethasone—multiple sclerosis	6.28e-06	0.000121	CcSEcCtD
Prednisone—Urticaria—Dexamethasone—multiple sclerosis	6.28e-06	0.000121	CcSEcCtD
Prednisone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	6.27e-06	0.000683	CbGpPWpGaD
Prednisone—Dizziness—Prednisolone—multiple sclerosis	6.26e-06	0.000121	CcSEcCtD
Prednisone—Asthenia—Triamcinolone—multiple sclerosis	6.25e-06	0.000121	CcSEcCtD
Prednisone—Abdominal pain—Betamethasone—multiple sclerosis	6.24e-06	0.000121	CcSEcCtD
Prednisone—Body temperature increased—Betamethasone—multiple sclerosis	6.24e-06	0.000121	CcSEcCtD
Prednisone—Body temperature increased—Dexamethasone—multiple sclerosis	6.24e-06	0.000121	CcSEcCtD
Prednisone—Abdominal pain—Dexamethasone—multiple sclerosis	6.24e-06	0.000121	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.24e-06	0.00068	CbGpPWpGaD
Prednisone—Asthenia—Methylprednisolone—multiple sclerosis	6.23e-06	0.00012	CcSEcCtD
Prednisone—Pruritus—Triamcinolone—multiple sclerosis	6.16e-06	0.000119	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	6.16e-06	0.000671	CbGpPWpGaD
Prednisone—Pruritus—Methylprednisolone—multiple sclerosis	6.15e-06	0.000119	CcSEcCtD
Prednisone—Convulsion—Methotrexate—multiple sclerosis	6.1e-06	0.000118	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.1e-06	0.000664	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.06e-06	0.00066	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	6.05e-06	0.000659	CbGpPWpGaD
Prednisone—Arthralgia—Methotrexate—multiple sclerosis	6e-06	0.000116	CcSEcCtD
Prednisone—Myalgia—Methotrexate—multiple sclerosis	6e-06	0.000116	CcSEcCtD
Prednisone—Rash—Prednisolone—multiple sclerosis	5.97e-06	0.000115	CcSEcCtD
Prednisone—Dermatitis—Prednisolone—multiple sclerosis	5.96e-06	0.000115	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.96e-06	0.000115	CcSEcCtD
Prednisone—Diarrhoea—Methylprednisolone—multiple sclerosis	5.94e-06	0.000115	CcSEcCtD
Prednisone—Headache—Prednisolone—multiple sclerosis	5.93e-06	0.000114	CcSEcCtD
Prednisone—Discomfort—Methotrexate—multiple sclerosis	5.93e-06	0.000114	CcSEcCtD
Prednisone—CYP2C19—Metabolism—SRM—multiple sclerosis	5.78e-06	0.000629	CbGpPWpGaD
Prednisone—Dizziness—Triamcinolone—multiple sclerosis	5.76e-06	0.000111	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—multiple sclerosis	5.75e-06	0.000111	CcSEcCtD
Prednisone—Dizziness—Methylprednisolone—multiple sclerosis	5.74e-06	0.000111	CcSEcCtD
Prednisone—Infection—Methotrexate—multiple sclerosis	5.71e-06	0.00011	CcSEcCtD
Prednisone—Asthenia—Dexamethasone—multiple sclerosis	5.67e-06	0.000109	CcSEcCtD
Prednisone—Asthenia—Betamethasone—multiple sclerosis	5.67e-06	0.000109	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.66e-06	0.000617	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—RPL5—multiple sclerosis	5.66e-06	0.000616	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SRM—multiple sclerosis	5.64e-06	0.000614	CbGpPWpGaD
Prednisone—Nervous system disorder—Methotrexate—multiple sclerosis	5.64e-06	0.000109	CcSEcCtD
Prednisone—Nausea—Prednisolone—multiple sclerosis	5.62e-06	0.000109	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.62e-06	0.000612	CbGpPWpGaD
Prednisone—Pruritus—Betamethasone—multiple sclerosis	5.59e-06	0.000108	CcSEcCtD
Prednisone—Pruritus—Dexamethasone—multiple sclerosis	5.59e-06	0.000108	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—multiple sclerosis	5.58e-06	0.000108	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IL6—multiple sclerosis	5.58e-06	0.000608	CbGpPWpGaD
Prednisone—Hyperhidrosis—Methotrexate—multiple sclerosis	5.56e-06	0.000107	CcSEcCtD
Prednisone—Vomiting—Triamcinolone—multiple sclerosis	5.54e-06	0.000107	CcSEcCtD
Prednisone—Vomiting—Methylprednisolone—multiple sclerosis	5.52e-06	0.000107	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.52e-06	0.000601	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	5.49e-06	0.000598	CbGpPWpGaD
Prednisone—Rash—Triamcinolone—multiple sclerosis	5.49e-06	0.000106	CcSEcCtD
Prednisone—Dermatitis—Triamcinolone—multiple sclerosis	5.48e-06	0.000106	CcSEcCtD
Prednisone—Anorexia—Methotrexate—multiple sclerosis	5.48e-06	0.000106	CcSEcCtD
Prednisone—Rash—Methylprednisolone—multiple sclerosis	5.48e-06	0.000106	CcSEcCtD
Prednisone—Dermatitis—Methylprednisolone—multiple sclerosis	5.47e-06	0.000106	CcSEcCtD
Prednisone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.47e-06	0.000596	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.46e-06	0.000594	CbGpPWpGaD
Prednisone—Headache—Triamcinolone—multiple sclerosis	5.45e-06	0.000105	CcSEcCtD
Prednisone—Headache—Methylprednisolone—multiple sclerosis	5.44e-06	0.000105	CcSEcCtD
Prednisone—Diarrhoea—Dexamethasone—multiple sclerosis	5.4e-06	0.000104	CcSEcCtD
Prednisone—Diarrhoea—Betamethasone—multiple sclerosis	5.4e-06	0.000104	CcSEcCtD
Prednisone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.35e-06	0.000583	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—multiple sclerosis	5.29e-06	0.000576	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.24e-06	0.000571	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.24e-06	0.000101	CcSEcCtD
Prednisone—Dizziness—Dexamethasone—multiple sclerosis	5.22e-06	0.000101	CcSEcCtD
Prednisone—Dizziness—Betamethasone—multiple sclerosis	5.22e-06	0.000101	CcSEcCtD
Prednisone—Insomnia—Methotrexate—multiple sclerosis	5.2e-06	0.0001	CcSEcCtD
Prednisone—Nausea—Triamcinolone—multiple sclerosis	5.17e-06	9.98e-05	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—multiple sclerosis	5.16e-06	9.96e-05	CcSEcCtD
Prednisone—Nausea—Methylprednisolone—multiple sclerosis	5.16e-06	9.96e-05	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—multiple sclerosis	5.06e-06	9.77e-05	CcSEcCtD
Prednisone—Vomiting—Dexamethasone—multiple sclerosis	5.02e-06	9.69e-05	CcSEcCtD
Prednisone—Vomiting—Betamethasone—multiple sclerosis	5.02e-06	9.69e-05	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—multiple sclerosis	5e-06	9.65e-05	CcSEcCtD
Prednisone—Rash—Dexamethasone—multiple sclerosis	4.98e-06	9.61e-05	CcSEcCtD
Prednisone—Rash—Betamethasone—multiple sclerosis	4.98e-06	9.61e-05	CcSEcCtD
Prednisone—Dermatitis—Betamethasone—multiple sclerosis	4.98e-06	9.6e-05	CcSEcCtD
Prednisone—Dermatitis—Dexamethasone—multiple sclerosis	4.98e-06	9.6e-05	CcSEcCtD
Prednisone—Fatigue—Methotrexate—multiple sclerosis	4.96e-06	9.57e-05	CcSEcCtD
Prednisone—Headache—Betamethasone—multiple sclerosis	4.95e-06	9.55e-05	CcSEcCtD
Prednisone—Headache—Dexamethasone—multiple sclerosis	4.95e-06	9.55e-05	CcSEcCtD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.83e-06	0.000526	CbGpPWpGaD
Prednisone—Feeling abnormal—Methotrexate—multiple sclerosis	4.74e-06	9.14e-05	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.7e-06	9.07e-05	CcSEcCtD
Prednisone—Nausea—Betamethasone—multiple sclerosis	4.69e-06	9.06e-05	CcSEcCtD
Prednisone—Nausea—Dexamethasone—multiple sclerosis	4.69e-06	9.06e-05	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.69e-06	0.000511	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITGA4—multiple sclerosis	4.64e-06	0.000506	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNB1—multiple sclerosis	4.61e-06	0.000502	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.57e-06	0.000498	CbGpPWpGaD
Prednisone—Urticaria—Methotrexate—multiple sclerosis	4.57e-06	8.81e-05	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—multiple sclerosis	4.54e-06	8.77e-05	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—multiple sclerosis	4.54e-06	8.77e-05	CcSEcCtD
Prednisone—ALB—Metabolism—CYP27B1—multiple sclerosis	4.53e-06	0.000494	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP24A1—multiple sclerosis	4.53e-06	0.000494	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PGR—multiple sclerosis	4.45e-06	0.000485	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.43e-06	0.000483	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	4.43e-06	0.000483	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.27e-06	0.000466	CbGpPWpGaD
Prednisone—Hypersensitivity—Methotrexate—multiple sclerosis	4.24e-06	8.17e-05	CcSEcCtD
Prednisone—ALB—Metabolism—GPC5—multiple sclerosis	4.15e-06	0.000452	CbGpPWpGaD
Prednisone—Asthenia—Methotrexate—multiple sclerosis	4.12e-06	7.96e-05	CcSEcCtD
Prednisone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.07e-06	0.000443	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.07e-06	0.000443	CbGpPWpGaD
Prednisone—Pruritus—Methotrexate—multiple sclerosis	4.07e-06	7.85e-05	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.06e-06	0.000443	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BCHE—multiple sclerosis	4.04e-06	0.00044	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.98e-06	0.000433	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.97e-06	0.000433	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.97e-06	0.000433	CbGpPWpGaD
Prednisone—Diarrhoea—Methotrexate—multiple sclerosis	3.93e-06	7.59e-05	CcSEcCtD
Prednisone—Dizziness—Methotrexate—multiple sclerosis	3.8e-06	7.34e-05	CcSEcCtD
Prednisone—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.72e-06	0.000406	CbGpPWpGaD
Prednisone—Vomiting—Methotrexate—multiple sclerosis	3.66e-06	7.05e-05	CcSEcCtD
Prednisone—ABCB1—Metabolism—GPC5—multiple sclerosis	3.63e-06	0.000396	CbGpPWpGaD
Prednisone—Rash—Methotrexate—multiple sclerosis	3.62e-06	7e-05	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—multiple sclerosis	3.62e-06	6.99e-05	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.61e-06	0.000393	CbGpPWpGaD
Prednisone—Headache—Methotrexate—multiple sclerosis	3.6e-06	6.95e-05	CcSEcCtD
Prednisone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.47e-06	0.000378	CbGpPWpGaD
Prednisone—ALB—Metabolism—RRM1—multiple sclerosis	3.44e-06	0.000374	CbGpPWpGaD
Prednisone—Nausea—Methotrexate—multiple sclerosis	3.41e-06	6.59e-05	CcSEcCtD
Prednisone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.22e-06	0.000351	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2RA—multiple sclerosis	3.17e-06	0.000346	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—VDR—multiple sclerosis	3.11e-06	0.000339	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.09e-06	0.000336	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RRM1—multiple sclerosis	3.01e-06	0.000328	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.81e-06	0.000307	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.78e-06	0.000303	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.77e-06	0.000302	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.76e-06	0.000301	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.72e-06	0.000296	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.67e-06	0.00029	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.59e-06	0.000282	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	2.57e-06	0.00028	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.45e-06	0.000267	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.45e-06	0.000267	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APOE—multiple sclerosis	2.43e-06	0.000265	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.39e-06	0.000261	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.29e-06	0.00025	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.24e-06	0.000244	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—POMC—multiple sclerosis	2.09e-06	0.000227	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.06e-06	0.000224	CbGpPWpGaD
Prednisone—ALB—Metabolism—BCHE—multiple sclerosis	1.97e-06	0.000215	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.9e-06	0.000207	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.87e-06	0.000204	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—multiple sclerosis	1.86e-06	0.000203	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.86e-06	0.000202	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.77e-06	0.000193	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.74e-06	0.00019	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.73e-06	0.000188	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—multiple sclerosis	1.45e-06	0.000158	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK1—multiple sclerosis	1.42e-06	0.000155	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—multiple sclerosis	1.24e-06	0.000135	CbGpPWpGaD
Prednisone—ALB—Metabolism—APOE—multiple sclerosis	1.19e-06	0.000129	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APOE—multiple sclerosis	1.07e-06	0.000116	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.07e-06	0.000116	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APOE—multiple sclerosis	1.04e-06	0.000113	CbGpPWpGaD
Prednisone—ALB—Metabolism—POMC—multiple sclerosis	1.02e-06	0.000111	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—POMC—multiple sclerosis	9.16e-07	9.98e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—POMC—multiple sclerosis	8.94e-07	9.74e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—multiple sclerosis	8.35e-07	9.09e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—multiple sclerosis	8.15e-07	8.88e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APOE—multiple sclerosis	6.41e-07	6.98e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—POMC—multiple sclerosis	5.51e-07	6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—multiple sclerosis	5.02e-07	5.47e-05	CbGpPWpGaD
